Skip to content

Clinical trials

Phase 1 Hepatitis C, Chronic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis C, Chronic Phase: Phase 1 Clear all

82 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20051
20064
20077
20087
20097
20104
20119
201213
201310
20144
20151
20162
20172
20183
20192
20203
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed69
Terminated8
Unknown status3
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC12
Sunshine Lake Pharma Co., Ltd.6
Boehringer Ingelheim5
Hoffmann-La Roche5
Alios Biopharma Inc.4
Gilead Sciences4
Bristol-Myers Squibb3
GlaxoSmithKline3
Tanabe Pharma Corporation3
Bader, Ted, M.D.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis C, Chronic82
Hepatitis C23
Liver Diseases3
Hepatitis, Viral, Human2
Infections2
Recurrence2
Virus Diseases2
Acquired Immunodeficiency Syndrome1
Camurati-Engelmann Syndrome1
Flaviviridae Infections1

Trials

Showing 26 to 50 of 82. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.